By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Angiotensin receptor blockers > Micardis > Micardis Side Effects
Angiotensin receptor blockers

Micardis Side Effects

Note: This document contains side effect information about telmisartan. Some dosage forms listed on this page may not apply to the brand name Micardis.

Applies to telmisartan: oral tablet.

Warning

Oral route (Tablet)

Drugs with direct action on the renin-angiotensin system can cause injury or death to the developing fetus. Stop therapy as soon as possible when pregnancy is detected.

Serious side effects of Micardis

Along with its needed effects, telmisartan (the active ingredient contained in Micardis) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking telmisartan:

Rare

  • Changes in vision
  • dizziness, lightheadedness, or fainting
  • fast heartbeat
  • large hives
  • painful urination or changes in urinary frequency
  • swelling in the hands, lower legs, and feet

Incidence not known

  • Blurred vision
  • chest pain or discomfort
  • confusion
  • dark-colored urine
  • decreased urine output
  • dilated neck veins
  • extreme fatigue
  • flushing
  • hives or welts
  • hoarseness
  • irregular breathing
  • irritation
  • itching
  • joint pain, stiffness, or swelling
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • muscle cramps or stiffness
  • numbness or tingling in the hands, feet, or lips
  • pain or discomfort in the arms, jaw, back, or neck
  • pounding in the ears
  • rash
  • redness of the skin
  • slow, fast, or irregular heartbeat
  • sweating
  • swelling of the eyelids, face, or lips
  • tightness in the chest
  • trouble breathing or swallowing
  • trouble with speaking or walking
  • trouble with thinking
  • unusual tiredness or weakness
  • unusually warm skin
  • weakness or heaviness of the legs
  • weakness, numbness, or tingling in the arms or legs
  • weight gain

Other side effects of Micardis

Some side effects of telmisartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Abdominal or stomach pain
  • back pain
  • bloating or gas
  • changes in appetite
  • coughing
  • diarrhea
  • dry mouth
  • ear pain or hearing problems
  • fever
  • general tiredness or weakness
  • headache
  • heartburn
  • increased sweating
  • muscle pain or spasm
  • nausea
  • nervousness
  • runny or stuffy nose
  • sneezing
  • sore throat

Incidence not known

  • Acid or sour stomach
  • belching
  • decreased interest in sexual intercourse
  • difficulty with moving
  • inability to have or keep an erection
  • indigestion
  • joint pain
  • lack or loss of strength
  • leg cramps
  • loss in sexual ability, desire, drive, or performance
  • muscle aching
  • stomach discomfort or upset
  • swelling
  • weakness

For Healthcare Professionals

Applies to telmisartan: oral tablet.

General

The most common adverse events reported in hypertension trials were back pain, sinusitis, and diarrhea. The most common adverse events reported in cardiovascular risk reduction trials were intermittent claudication and skin ulcer.[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, dyspepsia, nausea, abdominal pain

Uncommon (0.1% to 1%): Flatulence, vomiting, dry mouth, stomach discomfort, constipation, gastritis, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache[Ref]

Cardiovascular

Common (1% to 10%): Hypotension, palpitation, intermittent claudication, hypertension

Uncommon (0.1% to 1%): Bradycardia, orthostatic hypotension, tachycardia, angina pectoris, flushing, dependent edema, abnormal ECG

Postmarketing reports: Atrial fibrillation, congestive heart failure, myocardial infarction, blood pressure increased, hypertension aggravated[Ref]

Respiratory

Common (1% to 10%): Coughing, upper respiratory tract infection, sinusitis, pharyngitis, bronchitis

Uncommon (0.1% to 1%): Dyspnea, asthma, epistaxis, rhinitis

Very rare (less than 0.01%): Interstitial lung disease[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, myalgia, arthralgia, muscle spasms

Uncommon (0.1% to 1%): Gout, pain in extremity, arthritis

Rare (less than 0.1%): Tendon pain, blood creatine phosphokinase increased

Postmarketing reports: Rhabdomyolysis[Ref]

Psychiatric

Common (1% to 10%): Insomnia, anxiety, depression

Uncommon (0.1% to 1%): Nervousness[Ref]

Nervous system

Common (1% to 10%): Headache, dizziness

Uncommon (0.1% to 1%): Syncope, somnolence, migraine, paresthesia, hypoesthesia, cerebrovascular disorder

Rare (less than 0.1%): Dysgeusia[Ref]

Dermatologic

Common (1% to 10%): Rash, skin ulcer

Uncommon (0.1% to 1%): Pruritus, hyperhidrosis, eczema, dermatitis, sweating increased

Rare (less than 0.1%): Erythema, urticaria, drug eruption, toxic skin eruption[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection

Uncommon (0.1% to 1%): Micturition frequency, impotence, cystitis

Postmarketing reports: Erectile dysfunction[Ref]

Other

Common (1% to 10%): Pain, fatigue, influenza-like illness, chest pain, peripheral edema

Uncommon (0.1% to 1%): Vertigo, asthenia, tinnitus, earache, malaise, fever, leg edema

Postmarketing reports: Face edema[Ref]

Immunologic

Uncommon (0.1% to 1%): Infection, fungal infection, abscess, otitis media, allergy, sepsis

Rare (less than 0.1%): Anaphylactic reaction, angioedema, hypersensitivity

Postmarketing reports: Angioneurotic edema[Ref]

Metabolic

Uncommon (0.1% to 1%): Hyperkalemia, hypercholesterolemia, diabetes mellitus

Rare (less than 0.1%): Hypoglycemia in diabetic patients[Ref]

Hematologic

Uncommon (0.1% to 1%): Anemia, hemoglobin decreased

Rare (less than 0.1%): Eosinophilia, thrombocytopenia[Ref]

Renal

Uncommon (0.1% to 1%): Renal impairment including acute renal failure, blood creatinine increased

Rare (less than 0.1%): Blood uric acid increased

Frequency not reported: Acute renal failure[Ref]

Ocular

Uncommon (0.1% to 1%): Conjunctivitis, visual disturbance[Ref]

Hepatic

Rare (less than 0.1%): Hepatic function abnormal/liver disorder, hepatic enzyme increased[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by